Patent Analysis
Patent Analysis
Sale
The stem cell assay market was valued at USD 8.52 billion in 2023. It is expected to grow at a CAGR of 12.20% during the forecast period of 2024-2032 and attain a market value of USD 24.01 billion in 2032.
The increasing use of such platforms and ongoing technological advancements impact the market value. There has been a significant increase in the number of patent applications associated with stem cell assay, driven by the increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders, hence driving the need for assays and research on stem cells.
The Global Stem Cell Assay Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for global Stem Cell Assay includes a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within stem cell assay technologies.
Flow cytometry can be used in stem cell assays to identify, quantify, and characterize stem cells according to markers. It uses a laser beam to analyze the physical and chemical properties of individual cells or particles quickly and thoroughly in a fluid. To improve the accuracy and effectiveness of stem cell research and therapeutic applications, this technology is essential for evaluating the purity, viability, differentiation, and functional characteristics of stem cells. Therefore, innovations in such techniques have a significant impact on the patent landscape.
A stem cell assay is a type of laboratory procedure used to assess and quantify the properties and capacities of stem cells. This entails evaluating their capacity to divide, differentiate into distinct cell types, remain viable, and carry out a specific task. Stem cell assays are critical instruments in both research and clinical applications for developing regenerative medicine and cell-based therapies because they are vital for assessing the quality, potency, and therapeutic potential of stem cells.
The stem cell assay market continues to evolve, and the demand is fueled by the growth of the biotechnology and pharmaceutical sectors, which use stem cell assays for drug development and discovery. Also, the market is largely driven by government policies and initiatives that support stem cell research and development, hence boosting the market value in the forecast period.
Demand for High-throughput Screening (HTS) Platforms is Expected to Boost the Market Growth
High-throughput screening platforms that can effectively evaluate a compound's effects on stem cells are in greater demand as they help with toxicity testing and drug discovery. Leading manufacturers are creating and introducing cutting-edge HTS platforms specifically designed for assays involving stem cells.
For instance, in March 2022, Thermo Fisher Scientific Inc. unveiled a brand-new automated HTS platform that combines screening and stem cell culture features. Researchers can use this platform to screen compound libraries against stem cells on a large scale, which speeds up the process of finding possible therapeutic candidates and increases the effectiveness of drug development procedures. The introduction of such products in the market has boosted the incidence of patent applications.
Advancements in 3D Cell Culture Technologies is Expected to Propel the Stem Cell Assay Industry
3D cell culture technologies are becoming important for more physiologically relevant stem cell assays because of their improved ability to replicate in vivo environments when compared to traditional 2D cultures. Prominent manufacturing companies are advancing their use of 3D cell culture technologies in stem cell assays through innovation. Moreover, the patent application filings have increased from 19,769 patents in 2022 to 20,519 patents by 2023 due to the increasing advancements in stem cell-based assays.
The report provides an in-depth analysis of the patents in this field by the following segmentation -
Breakup by Product Type
Breakup by Technology
Breakup by Assay Type
Breakup by Cell Type
Breakup by Application
The breakup based on technology includes flow cytometry, high-content screening, PCR, spectrophotometry, microarray, and other technologies.
In stem cell assays, PCR (polymerase chain reaction) is an essential tool that allows the identification and measurement of specific gene expression profiles or genetic alterations in stem cells. PCR makes it easier to analyse stem cell differentiation, proliferation, and response to stimuli by amplifying target DNA sequences. This helps reveal the biological properties of the cells and their potential uses in regenerative medicine and drug discovery. Studying the behaviour of stem cells and their potential for therapy is more accurate and efficient when PCR is combined with stem cell assays.
The detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for stem cell assay patents, having around 285,400 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.
Holding a significant chunk of the global population, China is another vital jurisdiction and is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications.
Among the players with stem cell assay patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
F. Hoffmann-La Roche
A multinational pharmaceutical and diagnostics corporation has its main office in Switzerland. It is a pioneer in creating cutting-edge medical solutions, such as technologies and assays for stem cell therapy and research. Innovative methods for examining stem cell behaviour, differentiation, and therapeutic potential have been made possible by Roche's contributions to the field, which have aided in the development of regenerative medicine and drug discovery.
Thermo Fisher Scientific Inc.
It is a leader in the supply of scientific instruments, reagents, and services to the research, medical, and applied industries worldwide. The company provides a wide range of products designed specifically for use in stem cell research and assays, such as sophisticated cell culture systems, differentiation markers, and gene expression analysis assays. The cutting-edge technology from the company helps scientists explore drug discovery, stem cell biology, and regenerative medicine, which promotes improvements in personalized medicine and therapeutic development.
Other players include the University California, Pioneer Hi Bred International, Harvard College, and Genentech Inc, among others.
The Global Stem Cell Assay Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:
Scope of the Report | Details |
Analysis by Product Type |
|
Analysis by Technology |
|
Analysis by Assay Type |
|
Analysis by Cell Type |
|
Analysis by Application |
|
Key Players Mentioned |
|
Geographies Covered |
|
Global Stem Cell Therapy Market
Global Stem Cell Banking Market
Global Cell-Based Assays Market
North America Stem Cell Assay Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Introduction
2 Executive Summary
3 Global Stem Cell Assay Market Overview
3.1 Global Stem Cell Assay Market Historical Value (2017-2023)
3.2 Global Stem Cell Assay Market Forecast Value (2024-2032)
4 Global Stem Cell Assay Market Segmentation
4.1 Global Stem Cell Assay Market (2017-2032) By Product Type
4.1.1 Market Overview
4.1.2 Kits and Reagents
4.1.3 Instruments
4.1.4 Services
4.2 Global Stem Cell Assay Market (2017-2032) By Technology
4.2.1 Market Overview
4.2.2 Flow Cytometry
4.2.3 PCR
4.2.4 Spectrophotometry
4.2.5 Microarray
4.2.6 Other Technologies
4.3 Global Stem Cell Assay Market (2017-2032) By Assay Type
4.3.1 Market Overview
4.3.2 Viability/Cytotoxicity Assays
4.3.3 Isolation/Purification Assays
4.3.4 Differentiation Assays
4.3.5 Proliferation Assays
4.3.6 Apoptosis Assays
4.3.7 Other Assay Types
4.4 Global Stem Cell Assay Market (2017-2032) By Cell Type
4.4.1 Market Overview
4.4.2 Adult Stem Cells
4.4.3 Embryonic Stem Cells
4.4.4 Induced Pluripotent Stem Cells (iPSCs)
4.5 Services Global Stem Cell Assay Market (2017-2032) By Application
4.5.1 Market Overview
4.5.2 Drug Discovery and Development
4.5.3 Regenerative Medicine and Therapy Development
4.5.4 Clinical Research
4.5.5 Other Applications
4.6 Global Stem Cell Assay Market (2017-2032) by End User
4.6.1 Market Overview
4.6.2 Pharmaceutical and Biotechnology Companies
4.6.3 Research Institutes
4.6.4 Contract Research Organizations (CROs)
4.6.5 Others
5 Global Market Dynamics
5.1 Market Drivers and Constraints
5.2 Porter’s Five Forces Analysis
5.3 PESTEL Analysis
5.4 Industry Events, Initiatives, and Trends
5.5 Value Chain Analysis
6 Global Stem Cell Assay Patent Landscape Analysis
6.1 Patent Distribution by Publication Year
6.2 Patent Distribution by Application Year
6.3 Patent Distribution by Priority Year
6.4 Analysis by Type of Patent
6.4.1 Granted Patents
6.4.2 Patent Application
6.4.3 Amended Application
6.4.4 Search Report
6.5 Analysis by Legal Status
6.5.1 Active
6.5.2 Pending
6.5.3 Expired/Discontinued
6.6 Analysis by Patent Jurisdiction
6.7 Analysis by Patent Age
6.8 Analysis by Cooperative Patent Classification (CPC) Codes
6.9 Average Time to Publish a Patent
6.9.1 By Entities
6.9.2 By Jurisdiction
6.9.3 By Technology
6.10 Analysis by Type of Entity (Academic and Non-Academic)
6.11 Analysis by Top Applicants
6.12 Analysis by Top Inventors
7 Global Stem Cell Assay Patent Analysis by Technology
7.1 Total Patents by Top Technologies
7.2 Time Evolution of Patents by Technology
7.3 Emerging Technologies
7.4 Patent Segmentation, By Assay Type
7.4.1 Time Evolution by Number of Patents
7.4.2 Time Evolution by Number of Patent Families
7.4.3 Analysis by Type of Entity (Academic vs Non-Academic)
7.4.4 Analysis by Top Applicants
7.4.5 Analysis by Top Inventors
7.5 Patent Segmentation, By Cell Type
7.6 Patent Segmentation, By Application
*Complete technology list will be provided in the report.
8 EMR Patent Valuation Analysis
8.1 Assessment Methodology
8.2 High Value Patents
8.3 Medium Value Patents
8.4 Low Value Patents
9 Global Stem Cell Assay – Top 10 Players Patent Analysis
9.1 Top 10 Entities by Number of Patents
9.2 Analysis by Publication Year
9.3 Analysis by Application Year
9.4 Analysis by Priority Year
9.5 Analysis by Type of Patent
9.6 Analysis by Jurisdiction
9.7 Analysis by Cooperative Patent Classification (CPC) Codes
9.8 Analysis by Source of Innovation
9.9 Analysis by Forward and Backward Citations
9.10 Analysis by Legal Status
9.11 Analysis by Patent Age
9.12 Analysis by Key Inventors
9.13 Entity Dynamics
9.13.1 Analysis by Type of Player (Academic vs Non-Academic)
9.13.2 Analysis by Collaboration
9.13.3 Analysis by Technology
9.13.4 Newcomers
9.13.4.1 Start-up Companies
9.13.4.2 Established Companies
10 Patent Profile of Key Players
10.1 Thermo Fisher Scientific Inc.
10.1.1 Product Portfolio
10.1.2 Patent Portfolio by Patent Families
10.1.3 Time Evolution of Patents
10.1.4 Geographical Patent Coverage
10.1.5 Patent Analysis by Technology
10.1.6 Patent News and Developments
10.1.7 Financial Analysis
10.1.8 SWOT Analysis
10.2 F. Hoffmann-La Roche AG
10.3 Pioneer Hi Bred International
11 Future Trends
12 Global Stem Cell Assay Landscape (Additional Insight)*
12.1 Global Stem Cell Assay: Developers Landscape
12.1.1 Analysis by Year of Establishment
12.1.2 Analysis by Company Size
12.1.3 Analysis by Region
12.2 Global Stem Cell Assay: Product Landscape
12.2.1 Analysis by Product Type
12.2.2 Analysis by Technology
12.2.3 Analysis by Cell Type
*Additional insights are not provided in the standard report.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.